Clostridioides difficile is a leading cause of healthcare-associated diarrhea and is a known cause of antibiotic-associated diarrhea and pseudomembranous colitis. Laboratory tests and endoscopy have been used to diagnose C. difficile infection (CDI). Among the laboratory tests, the gold standard is the cell cytotoxicity assay and toxigenic C. difficile culture, which are difficult to use in hospital laboratories. Recently, a multi-step algorithm using a glutamate dehydrogenase assay, a nucleic acid amplification technique, and toxin A/B assay have been widely used clinically. This presentation will discuss strategies for better CDI diagnosis based on laboratory methods and recently recommended algorithms.
SD Biosensor, Inc., with its slogan ‘Beginning of all things that protect lives,’ is a global in-vitro diagnostics company that contributes to improving everyone’s quality of life by diagnosing diseases quickly and accurately. SD Biosensor is a Total Solution Provider in the IVD industry that develops and researches innovative diagnostic platforms. In 2020, SD Biosensor, Inc. began supplying numerous WHO prequalified for global public health diagnostic products, especially those for malaria, HIV, HCV, and COVID-19. Based on R&D know-how, Mass Production Capacity, and Global Sales Network, SD Biosensor, Inc. will continue to grow as a global biotech company by creating new value through accumulating data using AI as well as in the areas of diagnosis, products, and services. For further information, please see our official website at https://www.sdbiosensor.com/.
STANDARD™ M is a molecular diagnostic brand including STANDARD™ M10, a point-of-care molecular diagnostic system, PCR reagents and other related products. STANDARD™ M10 is a Versatile Point-of-Care MDx platform designed for more accurate, simpler, and faster clinical decision making near-the-patient using Real-time PCR or LAMP. STANDARD™ M10 is an automated system that integrates extraction and amplification of nucleic acids from various specimens and detection of target sequences. STANDARD™ M10 consists of STANDARD™ M10 Module and STANDARD™ M10 Console. The entire testing process is carried out inside STANDARD™ M10 Module, and STANDARD™ M10 Console controls the process, analyzes the result, and manages the database using the software. The patented all-in-one STANDARD™ M10 cartridges hold the nucleic acid extraction reagents and Real-time PCR/LAMP reagents. STANDARD™ M10 portfolio covers infectious disease diagnosis, drug resistance, and genetic testing.
STANDARD F is a fluorescent immunoassay brand. It is a multi-parametric and random accessible immunoassay system providing accurate diagnostic results to your laboratory. STANDARD F has over 50 parameters which can detect qualitative and quantitative. STANDARD F is detecting the results using F2400 and F200 analyzers. These analyzers have printing system inside so that a hand-written patient ID on the test device is printed with the result for user’s convenience. Also, it has a connectivity such as Bluetooth and LIS/HIS.